Ozempic's Popularity in China Sparks Supply Boost Efforts.

Ozempic, a popular diabetes drug, is in high demand in China for weight loss despite concerns from medical experts about serious side effects and rebound weight gain. The drug's popularity has caused shortages in the country, leading to problems for patients with diabetes who depend on the medication. The weight loss drug market in China is expected to boom in the coming years, with both Western and Chinese drugmakers vying for a slice of the growing market. Novo Nordisk, the manufacturer of Ozempic, has applied to China's drug regulator to widen the scope of use for semaglutide, and several Chinese firms have accelerated their development of generic versions of the drug.